New Breath of Life for Jeff

A Floridian since the 50s, Jeff Myck grew up breathing the fresh ocean air, singing along to the Beatles while doing housework, cooking or buying and selling Stamps. But 10 years ago he found himself with health issues, having a hard time catching his breath when doing simple everyday things, needing “a bag” of cough drops a day to help him swallow and breath and even getting laryngitis that lasted longer than normal. This led him to become anxious which caused tightening of his chest which complicated the problem. Concerned he saw specialist after specialist to try to diagnose what was wrong from a Rheumatologist, ENT and Cardiologist until they landed on the rare Alpha-1 antitrypsin deficiency (AATD).

AATD is a genetic condition when your body doesn’t produce enough of a protein that protects the lungs. As a result, those with AATD are more likely than others to suffer lung damage, especially when exposed to environmental stressors like air pollution. AATD is a condition that is not frequently diagnosed.

Fast forward to the present, Jeff has been getting weekly infusions of Prolastin (a treatment that has been proven to effectively raise alpha1-antitrypsin protein levels in patients with human plasma) for the past two years. Jeff can finally breathe again and now has less anxiety about doing normal tasks that might have given him trouble catching his breath, he is even down to a cough drop every once in a while and doing daily walks outside. “I look forward to my weekly treatments because my Sage Infusion treatment team always makes me feel comfortable and genuinely care for me and how I’m doing,” says Jeff.

He continued to share that this year he changed his insurance to Medicare Advantage and was a little nervous about whether there would be issues with the transition/switching of insurance. But no worries, the Sage financial experts made the transition smooth and he didn’t miss treatment or have to stress about it.

At Sage Infusion we have reimagined patient care and put patients first not only to help them navigate their infusion treatments but to work on behalf of each patient to secure all financial support.